Global /Italy /Healthcare /Medical Devices /STVN
chevron_leftBack
Stevanato Group S.p.A. logo

Stevanato Group S.p.A.

STVN
NYSE: STVN Delayed
16.26USD 0.3%
As of 7 June 2026, Stevanato Group S.p.A. has a market cap of $4.44B USD, ranking #4142 globally and #46 in Italy. It ranks #311 in the Healthcare sector, and #71 in the Medical Devices industry.
Global Rank
4142
Country Rank
46
Sector Rank
311
Industry Rank
71
Key Stats
Market Cap
$4.44BUSD
Enterprise Value
$4.79BUSD
Revenue (TTM)
$1.39BUSD
EBITDA (TTM)
$332.93MUSD
Net Income (TTM)
$164.19MUSD
EBITDA Margin
24%
Profit Margin
12%
PE Ratio
27.2
Forward PE
23.1
PS Ratio
3.2
PB Ratio
2.5
EV/EBITDA
14.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Franco Stevanato open_in_new
Employees
6,010
Founded
1949
IPO
16 Jul 2021
Website
stevanatogroup.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.3% 5.3% 20% 0.9% -37% -25%

News

Loading...

STVN Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
STVN
Stevanato Group SpA
ISIN: IT0005452658
Shares Out.:
49.71M1 Shares Float: 49.71M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
16.26 USD
Frankfurt Stock Exchange
MIC: XFRA
87N
Stevanato Group SpA
ISIN: IT0005452658
TV:
SA:
YF:
GF:
BA:
87N
MS:
13.70 EUR
Mexican Bolsa
MIC: XMEX
STVN-N (STVN/N)
Stevanato Group SpA
ISIN: IT0005452658
TV:
SA:
YF:
GF:
BA:
MS:
246.00 MXN
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Stevanato Group S.p.A.

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Similar Companies

Industry: Medical Devices (Italy)
Name
Market Cap diff.
PE
DIA
$3.57B
3.07B EUR
-20%
20.3
ELN
$1.21B
1.05B EUR
-73%
21.4
$804.96M
693.03M EUR
-82%
14.4
$55.92M
48.14M EUR
-99%
7.1
$28.57M
24.6M EUR
-99%
17.6
OTO
$27.01M
23.26M EUR
-99%
-
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
4K%
25.8
$160.73B
4K%
56.7
$159.07B
3K%
25.6
DHR
$126.55B
3K%
34.7
SYK
$120.69B
3K%
38.3
MDT
$101.9B
2K%
22.2
chevron_leftBack